Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: What studies are still needed?

21Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

The use of antibiotics in acute exacerbations of chronic bronchitis (AECBs) remains the subject of controversy despite considerable medical and socio-economic implications. First, the contribution of bacterial infection to AECBs is difficult to assess in patients with chronic obstructive pulmonary disease (COPD) who are chronically colonized with respiratory pathogens. In addition, several studies suggest a major role of viral infections in AECBs. Secondly, it is unlikely that all COPD patients will benefit from antibiotics during AECBs. In particular, the benefit in mild COPD remains uncertain. Unfortunately, the number of studies complying with evidence-based medicine requirements is too small for definite recommendations in AECBs to be drawn up. Considering the impact of acute exacerbations of chronic bronchitis on chronic obstructive pulmonary disease patients, as well as the community, and the impact of antibiotic therapy on the development of bacterial resistance, there is an urgent need for the design of appropriate multicentric studies to define the usefulness of this type of treatment in acute exacerbations of chronic bronchitis.

Cite

CITATION STYLE

APA

Sohy, C., Pilette, C., Niederman, M. S., & Sibille, Y. (2002). Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: What studies are still needed? European Respiratory Journal. https://doi.org/10.1183/09031936.02.00291302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free